Provided by Tiger Trade Technology Pte. Ltd.

Achieve Life Sciences, Inc.

8.14
+0.20002.52%
Volume:791.07K
Turnover:6.53M
Market Cap:835.64M
PE:-4.90
High:8.42
Open:8.04
Low:8.01
Close:7.94
52wk High:8.61
52wk Low:2.62
Shares:102.66M
Float Shares:73.95M
Volume Ratio:0.60
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6600
EPS(LYR):-1.2535
ROE:-844.99%
ROA:-29.21%
PB:-56.94
PE(LYR):-6.49

Loading ...

Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead Cmc, Supply Chain, and Quality

THOMSON REUTERS
·
Aug 03

Achieve Life Sciences Grants 1,190,000 Stock Options, 125,000 RSUs to New Hires Under Inducement Plan

Reuters
·
Jul 31

Achieve Life Sciences Posts Corporate Presentation on Cytisinicline Smoking-cessation Program

Reuters
·
Jul 30

Achieve Life Sciences Shareholders Approve Authorized Common Stock Increase to 300 Million Shares at Annual Meeting

Reuters
·
Jul 07

Achieve Life Sciences added to Russell 2000 Index

TIPRANKS
·
Jun 29

Achieve Life Sciences Joins Russell 2000® Index

THOMSON REUTERS
·
Jun 29

Analysts Are Bullish on Top Healthcare Stocks: Achieve Life Sciences (ACHV), Harmony Biosciences Holdings (HRMY)

TIPRANKS
·
Jun 24

Achieve Life Sciences Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 22

Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Nkarta (NKTX)

TIPRANKS
·
Jun 22

Achieve Life Sciences Shares Rise After Complete Response Letter From FDA

Dow Jones
·
Jun 22

Achieve Life Sciences CRL from FDA cites deficiencies at manufacturing facility

TIPRANKS
·
Jun 22

US FDA declines to approve Achieve Life Sciences' smoking-cessation drug

Reuters
·
Jun 22

Achieve Life Sciences gets FDA complete response letter for cytisinicline NDA over manufacturing deficiencies

Reuters
·
Jun 22

Achieve Life Sciences - FDA Crl Cites Manufacturing Observations and Incomplete Product Labeling

THOMSON REUTERS
·
Jun 22

Achieve Life Sciences Receives Complete Response Letter From FDA for Cytisinicline Nda

THOMSON REUTERS
·
Jun 22

Achieve Life Sciences - FDA Identifies No Deficiencies in Cytisinicline Efficacy or Safety

THOMSON REUTERS
·
Jun 22

Achieve Life Sciences announces annual shareholder meeting

Reuters
·
Jun 09

Achieve Life Sciences director Reid Waldman files initial beneficial ownership statement

Reuters
·
Jun 03

Achieve Life Sciences director Jeffrey S. Farrow files initial beneficial ownership statement

Reuters
·
Jun 03

Achieve Life Sciences adds Jeffrey Farrow, Reid Waldman to board

Reuters
·
Jun 02